Fingolimod, teriflunomide and cladribine for the treatment of multiple sclerosis in women of childbearing age: description of drug utilization and exposed pregnancies in Germany
Autor: | Platzbecker, Katharina a, ⁎, Wentzell, Nadine a, Kollhorst, Bianca b, Haug, Ulrike a, c |
---|---|
Zdroj: | In Multiple Sclerosis and Related Disorders November 2022 67 |
Databáze: | ScienceDirect |
Externí odkaz: |